JENNIFER HART: Open Payments
NPI 1275726812 · JAMESTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 15 payments from 11 companies in 2025. Trend: 2023 $207 · 2024 $249 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| PFIZER INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: TRELEGY ELLIPTA, CAPLYTA, NURTEC ODT, REXULTI, MOUNJARO, FANAPT, Auvelity, XIFAXAN.
Industry payments across KY — which companies pay providers there.
